0400 GMT - NextDC's bull at Jefferies sees the land held by the data-center operator for development lending further support to his valuation of the stock. Analyst Roger Samuel estimates that the Australia-listed company's existing assets are worth A$9 a share. After parsing several U.S. data-center land-bank portfolios, Samuel tells clients in a note that the next 600MW of assets he estimates NextDC can build through to fiscal 2031 are worth about A$10 a share. That A$19.00 total is just short of his unchanged target price of A$19.50, which is calculated on a discounted cash flow basis. He reckons NextDC looks relatively cheap given its total pipeline. Shares are down 0.2% at A$16.185. ([email protected])

0347 GMT - The convenience and performance of Life360's tech supports Morgan Stanley analysts' confidence that its new pet trackers will be a success. James Bale and Chenny Wang, who are overweight on the location-app provider, tell clients in a note that cheaper Bluetooth tracking devices are prone to performance issues. They also see Life360's ability to bundle pet tracking in with its existing subscription services as convenient for consumers. Users who pay the up-front cost of a Life360 pet-tracking device are also less likely to drop the subscription due to sunk-cost psychology, the analysts add. They keep a A$58.50 target price on Life360's Australia-listed stock, which is down 1.4% at A$49.45. ([email protected])

0332 GMT - Guzman Y Gomez's cooling share price lures a new bull to the Australia-listed Mexican-food chain. Macquarie initiates coverage of the stock with an outperform rating, in a note that highlights the stock's 40% slide from its recent peak. The investment bank's analysts tell clients that growth expectations have rebased, but at too low a level. They think that broader opening hours, expanded menu options and easing cost-of-living pressures can accelerate its sales growth. Any downside from a failure to expand in the U.S. is limited by exit optionality, they add. Macquarie puts a A$31.10 target price on the stock, which is up 0.4% at A$26.15. ([email protected])

0254 GMT - National Australia Bank's bull at Jefferies is looking to the lender's annual result announcement for details on how its business unit is holding up against increased competition. Analyst Andrew Lyons acknowledges concerns that NAB's traditional strength in business banking makes it more exposed than its peers to increased industry focus on the sector. Lyons' expectation for a 1.77% net interest margin for the second half of NAB's 2025 fiscal year compares with a consensus forecast of 1.73%. He tells clients in a note that he will be looking for any sign that competition is having an adverse margin impact. Jefferies lifts its target price 1.4% to A$46.16 and keeps a buy rating on the stock, which is up 2.4% at A$44.585. ([email protected])

2337 GMT - Investors are expected to view CSL's decision to delay a spinoff of flu-vaccine unit Seqirus positively, says RBC Capital Markets analyst Craig Wong-Pan. With U.S. flu-vaccine rates in decline, he says most investors didn't expect the spinoff to create value. Still, Wong-Pan says he expects CSL shares to underperform the market Tuesday given the company's announcement that it is cutting guidance, though he says the tempered growth outlook is "somewhat understandable given it has been mostly attributable to weakness in the influenza vaccine market." CSL shares are down some 15% to about A$180/share. ([email protected])

0521 GMT - Zip's new bulls at Macquarie are enthusiastic about the installment-payment company's opportunity with U.S. consumers underserved by traditional credit providers. Initiating coverage of the stock with an outperform rating, analysts at the investment bank tell clients that Zip's targeting of this niche demographic is driving the fastest growth in total transaction value of any buy-now-pay-later provider in the U.S. Customer engagement, strategic partnerships, and new customer acquisition should also help continue this rapid growth, they say. The analysts see potential for Zip to beat its fiscal 2026 margin guidance. Macquarie puts a A$4.85 target price on the stock, which closed 3.0% higher at A$4.09. ([email protected])

(END) Dow Jones Newswires